Reports
Sale
Global Periodontal Therapeutics Market Size, Analysis: By Product: Systemic Antibiotics, Local Antibiotics; By Treatment Type: Non-Surgical Treatment, Surgical Treatment; By Disease Type: Gingivitis, Chronic Periodontal Disease, Aggressive Periodontal Disease, Others; By End User; Regional Analysis; Supplier Landscape; 2024-2032
Global Periodontal Therapeutics Market Outlook
The global periodontal therapeutics market size attained a value of USD 2.82 billion in 2023, driven by growing incidence of diabetes. The market is anticipated to grow at a CAGR of 8.7% during the forecast period of 2024-2032 to attain a value of USD 5.98 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Segmentation
Periodontal diseases that trigger the destruction of the dentition supporting structures are prevalent chronic oral cavity infectious diseases. The periodontal therapeutics market can be divided on the basis of segments like products and distribution channels.
The periodontal therapeutics market can be divided on the basis of its product as systemic antibiotics and local antibiotics. Systemic antibiotics are further subdivided into doxycycline, minocycline, and metronidazole. Local antibiotics are also further subdivided into Arestin, Atridox, and PerioChip.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The periodontal therapeutics market can be broadly categorised based on its distribution channel into:
- Hospitals Pharmacies
- Retail Pharmacies
- Drug Stores
- E-commerce
The EMR report looks into the regional markets of periodontal therapeutics like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
Market Analysis
The growing incidence of diabetes is driving the global periodontal therapeutics market. Due to product affordability, accessibility, and elevated industry penetration, systemic antibiotics held the most significant share in the periodontal therapeutics market. They would further drive the periodontal therapeutics market growth during the forecast period. The rising incidence of periodontal diseases owing to a sedentary lifestyle, an effective reimbursement scenario, and an increasing geriatric population are the key drivers for the growth of the North American market for periodontal therapeutics.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Competitive Landscape
The report presents a detailed analysis of the following key players in the global periodontal therapeutics market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- 3M Company
- Den-Mat Holdings, LLC
- Dexcel Ltd.
- Kaken Pharmaceutical Co., Ltd.
- Bausch Health Companies Inc.
- Others
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Treatment Type |
|
| Breakup by Disease Type |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Periodontal Disease Overview
3.1 Guidelines and Stages
3.2 Pathophysiology
3.3 Screening and Diagnosis
3.4 Treatment Pathway
4 Patient Profile
4.1 Patient Profile Overview
4.2 Patient Psychology and Emotional Impact Factors
4.3 Risk Assessment and Treatment Success Rate
5 Periodontal Disease Epidemiology Analysis
5.1 Epidemiology Overview (2016-2031)
5.2 North America Periodontal Disease Epidemiology (2016-2031)
5.3 Europe Periodontal Disease Epidemiology (2016-2031)
5.4 Asia-Pacific Periodontal Disease Epidemiology (2016-2031)
5.5 Latin America Periodontal Disease Epidemiology (2016-2031)
5.6 Middle East & Africa Periodontal Disease Epidemiology (2016-2031)
6 Global Periodontal Therapeutics Market Overview
6.1 Global Periodontal Therapeutics Market Historical Value (2017-2023)
6.2 Global Periodontal Therapeutics Market Forecast Value (2024-2032)
7 Global Periodontal Therapeutics Market Landscape
7.1 Periodontal Therapeutics: Developers Landscape
7.1.1 Analysis by Year of Establishment
7.1.2 Analysis by Company Size
7.1.3 Analysis by Region
7.2 Periodontal Therapeutics: Product Landscape
7.2.1 Analysis by Product
7.2.2 Analysis by Treatment
7.2.3 Analysis by Disease Type
7.2.4 Analysis by End User
8 Periodontal Therapeutics Challenges and Unmet Needs
8.1 Treatment Pathway Challenges
8.2 Compliance and Drop-Out Analysis
8.3 Awareness and Prevention Gaps
9 Cost of Treatment
10 Global Periodontal Therapeutics Market Dynamics
10.1 Market Drivers and Constraints
10.2 SWOT Analysis
10.3 Porter’s Five Forces Model
10.4 Key Demand Indicators
10.5 Key Price Indicators
10.6 Industry Events, Initiatives, and Trends
10.7 Value Chain Analysis
11 Global Periodontal Therapeutics Market Segmentation
11.1 Global Periodontal Therapeutics Market by Product
11.1.1 Market Overview
11.1.2 Systemic Antibiotics
11.1.3 Local Antibiotics
11.2 Global Periodontal Therapeutics Market by Treatment Type
11.2.1 Market Overview
11.2.2 Non-Surgical Treatment
11.2.3 Surgical Treatment
11.3 Global Periodontal Therapeutics Market by Disease Type
11.3.1 Market Overview
11.3.2 Gingivitis
11.3.3 Chronic Periodontal Disease
11.3.4 Aggressive Periodontal Disease
11.3.5 Others
11.4 Global Periodontal Therapeutics Market by End User
11.4.1 Market Overview
11.4.2 Hospitals
11.4.3 Dental Clinics
11.4.4 Dental Academics and Research Institutes
11.4.5 Others
11.5 Global Periodontal Therapeutics Market by Region
11.5.1 Market Overview
11.5.2 North America
11.5.3 Europe
11.5.4 Asia Pacific
11.5.5 Latin America
11.5.6 Middle East and Africa
12 North America Periodontal Therapeutics Market
12.1 Market Share by Country
12.2 United States of America
12.3 Canada
13 Europe Periodontal Therapeutics Market
13.1 Market Share by Country
13.2 United Kingdom
13.3 Germany
13.4 France
13.5 Italy
13.6 Others
14 Asia Pacific Periodontal Therapeutics Market
14.1 Market Share by Country
14.2 China
14.3 Japan
14.4 India
14.5 ASEAN
14.6 Australia
14.7 Others
15 Latin America Periodontal Therapeutics Market
15.1 Market Share by Country
15.2 Brazil
15.3 Argentina
15.4 Mexico
15.5 Others
16 Middle East and Africa Periodontal Therapeutics Market
16.1 Market Share by Country
16.2 Saudi Arabia
16.3 United Arab Emirates
16.4 Nigeria
16.5 South Africa
16.6 Others
17 Regulatory Framework
17.1 Regulatory Overview
17.1.1 US FDA
17.1.2 EU EMA
17.1.3 INDIA CDSCO
17.1.4 JAPAN PMDA
17.1.5 Others
18 Patent Analysis
18.1 Analysis by Type of Patent
18.2 Analysis by Publication year
18.3 Analysis by Issuing Authority
18.4 Analysis by Patent Age
18.5 Analysis by CPC Analysis
18.6 Analysis by Patent Valuation
18.7 Analysis by Key Players
19 Grants Analysis
19.1 Analysis by year
19.2 Analysis by Amount Awarded
19.3 Analysis by Issuing Authority
19.4 Analysis by Grant Application
19.5 Analysis by Funding Institute
19.6 Analysis by NIH Departments
19.7 Analysis by Recipient Organization
20 Clinical Trials Analysis
20.1 Analysis by Trial Registration Year
20.2 Analysis by Trial Status
20.3 Analysis by Trial Phase
20.4 Analysis by Therapeutic Area
20.5 Analysis by Geography
21 Funding and Investment Analysis
21.1 Analysis by Funding Instances
21.2 Analysis by Type of Funding
21.3 Analysis by Funding Amount
21.4 Analysis by Leading Players
21.5 Analysis by Leading Investors
21.6 Analysis by Geography
22 Partnership and Collaborations Analysis
22.1 Analysis by Partnership Instances
22.2 Analysis by Type of Partnership
22.3 Analysis by Leading Players
22.4 Analysis by Geography
23 Supplier Landscape
23.1 3M Company
23.1.1 Financial Analysis
23.1.2 Product Portfolio
23.1.3 Demographic Reach and Achievements
23.1.4 Mergers and Acquisitions
23.1.5 Certifications
23.2 Den-Mat Holdings, LLC
23.2.1 Financial Analysis
23.2.2 Product Portfolio
23.2.3 Demographic Reach and Achievements
23.2.4 Mergers and Acquisitions
23.2.5 Certifications
23.3 Dexcel Pharma
23.3.1 Financial Analysis
23.3.2 Product Portfolio
23.3.3 Demographic Reach and Achievements
23.3.4 Mergers and Acquisitions
23.3.5 Certifications
23.4 Kaken Pharmaceutical Co., Ltd.
23.4.1 Financial Analysis
23.4.2 Product Portfolio
23.4.3 Demographic Reach and Achievements
23.4.4 Mergers and Acquisitions
23.4.5 Certifications
23.5 Bausch Health Companies Inc.
23.5.1 Financial Analysis
23.5.2 Product Portfolio
23.5.3 Demographic Reach and Achievements
23.5.4 Mergers and Acquisitions
23.5.5 Certifications
23.6 Colgate-Palmolive Company (India) Limited
23.6.1 Financial Analysis
23.6.2 Product Portfolio
23.6.3 Demographic Reach and Achievements
23.6.4 Mergers and Acquisitions
23.6.5 Certifications
23.7 Mylan N.V.
23.7.1 Financial Analysis
23.7.2 Product Portfolio
23.7.3 Demographic Reach and Achievements
23.7.4 Mergers and Acquisitions
23.7.5 Certifications
23.8 WOCKHARDT
23.8.1 Financial Analysis
23.8.2 Product Portfolio
23.8.3 Demographic Reach and Achievements
23.8.4 Mergers and Acquisitions
23.8.5 Certifications
23.9 Pfizer Inc
23.9.1 Financial Analysis
23.9.2 Product Portfolio
23.9.3 Demographic Reach and Achievements
23.9.4 Mergers and Acquisitions
23.9.5 Certifications
23.10 Noveome Biotherapeutics, Inc
23.10.1 Financial Analysis
23.10.2 Product Portfolio
23.10.3 Demographic Reach and Achievements
23.10.4 Mergers and Acquisitions
23.10.5 Certifications
24 Periodontal Therapeutics - Distribution Model (Additional Insight)
24.1 Overview
24.2 Potential Distributors
24.3 Key Parameters for Distribution Partner Assessment
25 Key Opinion Leaders (KOL) Insights (Additional Insight)
26 Company Competitiveness Analysis (Additional Insight)
26.1 Very Small Companies
26.2 Small Companies
26.3 Mid-Sized Companies
26.4 Large Companies
26.5 Very Large Companies
27 Payment Methods (Additional Insight)
27.1 Government Funded
27.2 Private Insurance
27.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
In 2023, the global market periodontal therapeutics attained a value of USD 2.82 billion.
The market is anticipated to grow at a CAGR of 8.7% during the forecast period of 2024-2032 to reach a value of USD 5.98 billion by 2032.
The rising incidence of diabetes along with the affordability and accessibility of the therapeutic products and services are the major driver for the global market.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America has been leading the global market.
The products in the market include systemic antibiotics and local antibiotics.
The treatment types include non-surgical treatment and surgical treatment.
The disease types can be categorised into gingivitis, chronic periodontal disease, and aggressive periodontal disease, among others.
The end-users include hospitals, dental clinics, dental academics and research institutes, among others.
Key players involved in the market are 3M Company, Den-Mat Holdings, LLC, Dexcel Pharma, Kaken Pharmaceutical Co., Ltd., Bausch Health Companies Inc., Colgate-Palmolive Company (India) Limited, Mylan N.V., Pfizer Inc, Noveome Biotherapeutics, Inc., and WOCKHARDT.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 3499
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5999
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 7999
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 9999
$5999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER